FR2361896A1 - Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament - Google Patents

Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament

Info

Publication number
FR2361896A1
FR2361896A1 FR7631723A FR7631723A FR2361896A1 FR 2361896 A1 FR2361896 A1 FR 2361896A1 FR 7631723 A FR7631723 A FR 7631723A FR 7631723 A FR7631723 A FR 7631723A FR 2361896 A1 FR2361896 A1 FR 2361896A1
Authority
FR
France
Prior art keywords
preparation
application
medicinal product
cephalosporin derivatives
new cephalosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7631723A
Other languages
English (en)
Other versions
FR2361896B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/704,142 external-priority patent/US4118491A/en
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2361896A1 publication Critical patent/FR2361896A1/fr
Application granted granted Critical
Publication of FR2361896B1 publication Critical patent/FR2361896B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Abstract

L'invention concerne des acides céphalosporaniques et leurs sels. Les composés en question répondent à la formule suivante :
FR7631723A 1975-10-30 1976-10-21 Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament Granted FR2361896A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62716475A 1975-10-30 1975-10-30
US66583776A 1976-03-11 1976-03-11
US05/704,142 US4118491A (en) 1976-03-11 1976-07-12 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them

Publications (2)

Publication Number Publication Date
FR2361896A1 true FR2361896A1 (fr) 1978-03-17
FR2361896B1 FR2361896B1 (fr) 1979-02-23

Family

ID=27417417

Family Applications (3)

Application Number Title Priority Date Filing Date
FR7631723A Granted FR2361896A1 (fr) 1975-10-30 1976-10-21 Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament
FR7708504A Granted FR2351982A1 (fr) 1975-10-30 1977-03-22 Derives de cephalosporine
FR7708505A Granted FR2337720A1 (fr) 1975-10-30 1977-03-22 Sulfamino alkyl tetrazole thiols

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR7708504A Granted FR2351982A1 (fr) 1975-10-30 1977-03-22 Derives de cephalosporine
FR7708505A Granted FR2337720A1 (fr) 1975-10-30 1977-03-22 Sulfamino alkyl tetrazole thiols

Country Status (17)

Country Link
JP (1) JPS6053026B2 (fr)
AT (1) AT353957B (fr)
AU (1) AU505141B2 (fr)
CA (1) CA1071188A (fr)
CH (1) CH627757A5 (fr)
DE (1) DE2649545A1 (fr)
DK (1) DK463176A (fr)
ES (1) ES452769A1 (fr)
FI (1) FI60868C (fr)
FR (3) FR2361896A1 (fr)
GB (3) GB1570094A (fr)
GR (1) GR61667B (fr)
IE (1) IE44393B1 (fr)
IL (3) IL50546A (fr)
LU (1) LU76092A1 (fr)
NL (1) NL7612010A (fr)
SE (3) SE452621B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117123A (en) * 1977-06-09 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
AT383811B (de) * 1983-09-22 1987-08-25 Biochemie Gmbh Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
US4717531A (en) * 1983-09-23 1988-01-05 Westinghouse Electric Corp. Fuel transfer system upender using translation drive

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2223002A1 (fr) * 1973-03-30 1974-10-25 Fujisawa Pharmaceutical Co

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110338A (en) * 1973-10-31 1978-08-29 Fujisawa Pharmaceutical Co., Ltd. Product and preparation of 1H-tetrazole-5-thiol derivatives
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2223002A1 (fr) * 1973-03-30 1974-10-25 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
FR2351982B1 (fr) 1981-07-03
FR2337720B1 (fr) 1981-07-10
ES452769A1 (es) 1978-01-16
IE44393L (en) 1977-09-11
JPS5257191A (en) 1977-05-11
IL56757A0 (en) 1979-05-31
GR61667B (en) 1978-12-05
FR2361896B1 (fr) 1979-02-23
FI60868B (fi) 1981-12-31
GB1570095A (en) 1980-06-25
IL50546A0 (en) 1976-11-30
IL50546A (en) 1980-07-31
SE7610722L (sv) 1977-05-01
LU76092A1 (fr) 1977-05-17
CA1071188A (fr) 1980-02-05
FR2337720A1 (fr) 1977-08-05
CH627757A5 (en) 1982-01-29
AT353957B (de) 1979-12-10
AU505141B2 (en) 1979-11-08
ATA807276A (de) 1979-05-15
AU1870276A (en) 1978-04-20
GB1570093A (en) 1980-06-25
DK463176A (da) 1977-05-01
SE435291B (sv) 1984-09-17
JPS6053026B2 (ja) 1985-11-22
FI763044A (fr) 1977-05-01
SE452621B (sv) 1987-12-07
SE437025B (sv) 1985-02-04
IL56758A0 (en) 1979-05-31
SE8006414L (sv) 1980-09-12
GB1570094A (en) 1980-06-25
NL7612010A (nl) 1977-05-03
SE8006413L (sv) 1980-09-12
DE2649545A1 (de) 1977-05-12
FR2351982A1 (fr) 1977-12-16
FI60868C (fi) 1982-04-13
IE44393B1 (en) 1981-11-18

Similar Documents

Publication Publication Date Title
FR2387234A1 (fr) Derives de cephalosporine, leur procede de preparation et leurs applications en therapeutique
FR2385722A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
FR2432500A1 (fr) Nouveaux derives de la benzene propanamine et leurs sels, procede de preparation et application a titre de medicaments
FR2453155A1 (fr) Derives de cyanoguanidine, leur procede de preparation et leurs applications en therapeutique
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
FR2362628A1 (fr) Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2359144A1 (fr) Sels de l'acide clavulanique utilisable comme medicaments
FR2405246A1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et leurs applications en therapeutique
BE881631A (fr) Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
FR2370028A1 (fr) Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments
FR2453151A1 (fr) Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique
FR2417502A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2432520A1 (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2361897A1 (fr) Nouveaux derives de la cephalosporine, leurs intermediaires et procede pour les preparer
FR2362845A1 (fr) Nouveaux derives de o-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2355849A1 (fr) Derives de l'acide 7 b-acylamidoceph-3-eme 4-carboxyliques, leur procede de preparation et application therapeutique
FR2361371A1 (fr) Nouvelles 2-phenylamino imidazolines-(2) substituees, leurs sels d'addition avec des acides, les medicaments les renfermant et procedes pour leur preparation
FR2387230A1 (fr) Nouvelles pyrroloquinoxalines et leurs sels, procede de preparation et application a titre de medicaments
FR2417503A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
FR2361896A1 (fr) Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament

Legal Events

Date Code Title Description
ST Notification of lapse